It’s a safe bet that no one came to Sunday night’s ohGr concert expecting to witness any moments that could be described, with no trace of irony, as “sweet”, but such a moment took place in any case.

ohGr (due tonight at the Bluebird Theater with Left Spine Down and Orbit Service) is a project involving Mark Walk and Ogre (aka Kevin Ogilvie), the legendary frontman from influential and pioneering ...

Skinny Puppy has stopped by FashioNation (613 E. 13th Ave.) quite a few times over the years. So has Ministry, Front 242, KMFDM, Peter Murphy, Motorhead, Social Distortion…well, you get the idea. See ...

One Health Group PLC Annual stock financials by MarketWatch. View the latest OHGR financial statements, income statements and financial ratios.

Canadian Nivek Ogre, the mastermind behind cult industrial icons Skinny Puppy, now performs under the moniker OhGR with former Skinny Puppy member Mark Walks. OhGR is like a darker, less explosive ...

On sale: Friday, 6/22 @ 10am Door 7 / Show 8 First born under the name "W.E.L.T." the project was frequently on the back burner for several years until it began to coagulate in Seattle beginning a ...

The projected fair value for One Health Group is UK£1.60 based on Dividend Discount Model One Health Group's UK£2.14 share price signals that it might be 34% overvalued The average discount for One ...

What is the current share price of One Health Group PLC (OHGR)? One Health Group PLC's (OHGR) current share price is 236.00p. This constitutes a price movement of 7.09% when compared to the share ...

As half of Skinny Puppy, Nivek Ogre (or just Ogre, or Kevin Ogilvie) created, in the Eighties, a much-imitated, arresting blend of industrial and hard rock, belched forth amid bewildering onstage ...

You can read a lot into the title of “Tricks,” Nivek Ogre’s bracing new political treatise from his Skinny Puppy side project ohGr. Tricks were what helped elect a game show host to the highest office ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.